Intermittent versus continuous erlotinib with concomitant modified ‘XELOX’ (q3W) in first-line treatment of metastatic colorectal cancer (mCRC)
Invited conference paper presented and published in conference proceedings


全文

其它資訊
著者MA Buig Yue Brigette, CHAN Lam Stephen, HO Ming Wing, POON Annette Ngar, HUI Pun Edwin, DATTATRAY R D, WONG S C, CHAN Anthony Tak Cheung
會議名稱35th ESMO Congress
會議開始日08.10.2010
會議國家/地區意大利
會議論文集題名35th ESMO Congress
出版年份2010
月份10
出版地Italy
頁次1
語言英式英語
關鍵詞XELOX

上次更新時間 2018-23-01 於 18:12